Clinical Trials on Non-Small Cell Lung Cancer in Korea, Democratic People's Republic of
Total 1136 results
-
Dong-A University HospitalCompletedColorectal Cancer | Pancreatic Cancer | Non-small Cell Lung CancerKorea, Republic of
-
GlaxoSmithKlineCompletedPathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)Singapore, Korea, Republic of
-
PfizerCompletedNon-small Cell Lung CancerKorea, Republic of, United States
-
Ono Pharmaceutical Co. LtdCompletedAdvanced Non-small Cell Lung CancerKorea, Republic of
-
Dong-A University HospitalCompletedPancreatic Cancer | Non-small Cell Lung CancerKorea, Republic of
-
AstraZenecaParexelTerminatedNon Small Cell Lung CancerUnited States, Korea, Republic of
-
Samsung Medical CenterUnknownNonsmall Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterNational Evidence-Based Healthcare Collaborating AgencyRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of
-
PfizerCompletedCarcinoma, Non Small Cell LungKorea, Republic of
-
Genzyme, a Sanofi CompanyCompleted
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerFrance, Korea, Republic of, United Kingdom, Spain
-
Therapex Co., LtdRecruitingCarcinoma, Non-Small-Cell Lung | EGFR Mutant Advanced Non-Small Cell Lung CancerKorea, Republic of
-
Wellmarker BioMerck Sharp & Dohme LLCRecruitingHead and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Advanced Solid Tumor | Metastatic Solid TumorKorea, Republic of
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
National Cancer Center, KoreaMerck Sharp & Dohme LLCUnknownNon-Small-Cell Lung CarcinomaKorea, Republic of
-
Pusan National University HospitalYuhan CorporationNot yet recruitingNon-small Cell Lung CancerKorea, Republic of
-
National Cancer Center, KoreaCompleted
-
AstraZenecaCompletedEGFR Mutation Positive Advanced Non Small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Australia
-
Samsung Bioepis Co., Ltd.RecruitingNon-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage IIKorea, Republic of, Poland, Spain, Turkey
-
J Ints BioRecruitingEGFR Mutant Advanced Non-small Cell Lung CancerKorea, Republic of, United States, Thailand
-
Eli Lilly and CompanyAstraZenecaCompletedNon-small Cell Lung CancerSpain, United States, Korea, Republic of, Taiwan, France
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerTaiwan, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerBelgium, United States, Korea, Republic of, Taiwan, United Kingdom, Netherlands
-
Samsung Medical CenterAstraZenecaTerminatedSmall Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterTerminated
-
Samsung Medical CenterAstraZenecaTerminatedSmall Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterCompletedSmall Cell Lung CancerKorea, Republic of
-
Novartis PharmaceuticalsTerminatedSquamous Non-small Cell Lung CancerGermany, Spain, Korea, Republic of, Belgium, Italy, United States, France, Sweden
-
Seoul National University HospitalUnknownNon Small Cell Lung Cancer PatientsKorea, Republic of
-
Samsung Medical CenterUnknownNonsmall Cell Lung CancerKorea, Republic of
-
Chonnam National University HospitalChong Kun Dang PharmaceuticalCompletedCarcinoma, Small CellKorea, Republic of
-
AstraZenecaDaiichi SankyoRecruitingNon-small Cell Lung CancerGermany, Taiwan, Australia, China, Korea, Republic of
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerTaiwan, Spain, Italy, United States, Korea, Republic of, France
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
Seoul National University HospitalCompletedSmall Cell Lung CancerKorea, Republic of
-
Novartis PharmaceuticalsRecruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Spain, Japan, Germany, Switzerland
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerUnited States, Taiwan, Italy, Korea, Republic of
-
National Cancer Center, KoreaRoche Korea co.,Ltd.RecruitingSequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLC (Atezolizumab)Small Cell Lung Cancer RecurrentKorea, Republic of
-
Samsung Medical CenterCompletedSmall Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterCompleted
-
Gachon University Gil Medical CenterUnknownSmall Cell Lung CancerKorea, Republic of
-
Yonsei UniversityCompletedLung CancerKorea, Republic of
-
Samsung Medical CenterCompletedSmall Cell Lung CancerKorea, Republic of
-
JI-YOUN HANNational Cancer Center, KoreaCompletedSmall Cell Lung Cancer | Small Cell Lung Cancer RecurrentKorea, Republic of
-
ETOP IBCSG Partners FoundationHoffmann-La Roche; AstraZenecaActive, not recruitingNon Small Cell Lung Cancer MetastaticIreland, Singapore, Spain, Switzerland, Korea, Republic of, Netherlands
-
Novartis PharmaceuticalsCompletedNon-small-cell Lung CancerCanada, France, Spain, Netherlands, Singapore, Germany, Korea, Republic of, Turkey, United States, Norway
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
Samsung Medical CenterUnknownSmall Cell Lung CancerKorea, Republic of
-
Konkuk University Medical CenterYuhan CorporationRecruitingNon Small Cell Lung CancerKorea, Republic of